Ireland | Not Applicable | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
Treasury Building, Lower Grand Canal Street, Dublin 2, Ireland | Not Applicable | |
(Address of principal executive offices) | (Zip Code) |
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Exhibit 10.1 | Share Purchase Agreement, dated as of November 6, 2014, by and among the Company, Alychlo and Holdco (filed as exhibit 10.1 to the Current Report on Form 8-K filed by the Company on November 11, 2014 and incorporated herein by reference). | |
Exhibit 99.1 | Press Release issued by Perrigo Company plc, dated March 30, 2015. |
PERRIGO COMPANY PLC | ||||
(Registrant) | ||||
By: | /s/ Todd W. Kingma | |||
Dated: March 30, 2015 | Todd W. Kingma | |||
Executive Vice President, General Counsel and Secretary | ||||
Exhibit 10.1 | Share Purchase Agreement, dated as of November 6, 2014, by and among the Company, Alychlo and Holdco (filed as exhibit 10.1 to the Current Report on Form 8-K filed by the Company on November 11, 2014 and incorporated herein by reference). | |
Exhibit 99.1 | Press Release issued by Perrigo Company plc, dated March 30, 2015. |
• | Advances Perrigo’s stated strategy to expand internationally and leverage the combined product portfolio of Perrigo and Omega |
• | Combines Perrigo’s supply chain and operational excellence with Omega’s OTC branding and regulatory expertise |
• | Establishes broad global commercial presence and creates multiple opportunities to cross-sell Perrigo products in diverse new channels |
• | Advances International Growth Strategy |
◦ | Expands market access across a larger global platform with critical mass in all key European countries |
◦ | Establishes commercial infrastructure in the high-barrier to entry European OTC marketplace |
◦ | Positions Perrigo to capture additional share of the $30 billion European OTC market |
◦ | Broadens opportunities for continued strategic bolt-on acquisitions |
• | Strengthens Product Portfolio While Enhancing Scale and Distribution |
◦ | Leverages Perrigo’s leading consumer health portfolio into Omega’s European commercial network |
◦ | Combines Perrigo’s supply chain and operational excellence with Omega’s OTC branding and regulatory expertise |
◦ | Provides leadership position in a durable, European OTC cash pay market |
• | Financially Compelling |
◦ | Enhances Perrigo’s strong financial profile through substantially diversified revenue and cash flow streams |
◦ | Strong pro forma operating cash flow enables rapid deleveraging post-close |
◦ | Accretive to Perrigo standalone revenue, adjusted operating income growth rates (on a constant currency basis) and cash flow generation |
• | Expands International Management Capabilities |
◦ | Marc Coucke brings over 25 years of branded OTC leadership experience to the Perrigo executive committee |
◦ | Broadens European consumer and pharmacist-centric management capabilities |
◦ | Adds approximately 2,500 employees, including a large sales team of approximately 1,100 individuals |
NF/@V!%(P,+R2PV M4)TM1$&JOZE*8[1+57[80@E3X-?^#YP0A2!$(`$)*``"YDSG.MMYS@,`D*E$ M(#*2F:QT*0O,A//0LI?%;&95D1U'#`)BG?%L1B6&B/:XX8@F@,A``UQ` M!AEX(`(S.$H-:L""`SP"'?LX"%95D`,@6!@(,W!!,(JLU($8YR*-X0 CL4SCLJHIDO M)H11-N,T?S(V $$'1YC%BS5B9+'6ZQR%J(!YC:*#'6#` MWUI1*9G^!9*+-\1A#G:8@QS@T(=H7'%A6FD*8=JA"TG0008*4$`#=KYS!,!9 M!6T0Q"9X80Z-M!`;@I"#'>QPASK`@1#?2(_V&,*0S?#C&X20PQVV?H>G?\,X MB4Z,Q@12BC7(H0YSB(, 519;>5(!`F&=Q,(,``">'\`3Q;`][NG@`8Q MY4$-@D"#`CBB-#`NS&S\(8Q,]($,$Y#``NZ.``4X``-H($0I7/X;>%39W"8Q MB#5B80E!J&$!`Q@``8#^VDZP8A?-R(8Y2JG&?;!C'-EX1C!DD0I/1,(0?8C# M$CQ@@09`H`,ED!!2D`(#33<@`A10P1C:P(=#2,(3K?"%,L3^X0_]A829]'P5 M/YRA!A!4P0E8D,`F"D.NDGS6( X`4_0`0D\P2$AS=` M,`1%0!XL"`8S]3( (58F(5:N(5< MV(5>^(7$M$0NX2L]]0_5DF5@F(8(2!:QP`%/``0Z``15$`8O(S\*1H0\`"-7 M8'\-\`&$`!L:L5]9H39J*!`&`1G^'(,5QX$8_5>(*?%1?Q(H)54H9-0.T*`* M?C`!+'`%1!`^0^`$)9`&O21/@N:(6(8M_#`,@8`!%7`!=G`+^T`G%H&&CJ@2 MR(8P>],5('$9_'`+,C`#-``&8>`$1@`!@\`..#(KB580D6&(D5$ /$#T/)E;N!R[?@.JC:`+V1B%Y-= M\9`0/44;RU%#QA$:NX@0M!&0/_1.&`D2R<@/YI`+JB`+W!`:GQ<:MX$MHF$2 M8R02_O#^#,,P%DW1-P%)BR%QFI@!C*@`AR``"$``TC`(7&3!%7@`&G^D$2IF`8D0528"PE M8`:EX)L$-`MQ``$^@H*AU`"!P`TZ5%V[@`Q;P5):%A/=92Q$\'P-P'<-P``/ MP`$GD`9_P%@7I9#\``QDP`(UL&!7\`#C M`!-8$W45`"<.!BW0<9.B42W`4H3L`";<`W_B!/W;=#6,%,U\@/QZ`& M+$!4F/HE1)`#4/`$.9`#1%"MVTH$4``%KA8C6X`$,!`#ME"G 3J`K<[`-LX(QRI05(`:I/5-B\*`VJ.``].<#VVH!DK`-!-0*:``" M2<`F44`";]`,&MD+2L`"H?0B1)`!EA4KVH52!^$/A@`!4.`#3B`&.\`">>`- M',$Q3M7^96#``FNP;%6QD[.Q"TL``T-@A"RP!,)@%G;*9R-#;H`&$BHS:(6V M;HBF?XN&,P_@:#VS81&9+>S@"6B@!57P!&RV@O.)7E&@`RP``15P!ZM0&E6& M(_R0"THP`U&`(.B'`4G$H5>UBY11+_[0"`V0E3>&!2LP!]"%/R;!CPG#-\PV M&Y70`)^(HU?0`G&`#6ES,:7H1!@#CQ!!$1'A.>/V9RA#M(*F.H;V.C2C:#?3 M:/-&!!)0(V,!"0B`@D00`HA0-5VQ'` W7LLGFCRH!%E7][^H`<0L)[?!80* MX`>\4$J'8G4$@0VKP%>= VCMIK2A&V]-.[H68&^W$`,YX&1@ MPP%^D`K#(`W8$,`"',#:4,#@L&.RFSTU.0H6,`-RB`3HA0![,&LC,0Z6@+M@ M4`18$#XD8`:PH9+9M3^W$5]88()&``0@8%(<\9$G,77R4"_M4`IIH(E.``8T M%82($P0JZ"UA0`0DT`;:P!'Z8`UO4`)@$`6Y,CK@X!!5B"CW,V@A@`5!"(IT M`#N?154"1!:@P*)A\`6XV0"G$!ON8`Z%H!IBX,57L":?Z`1K`2/35EY.`,%* M$B,5P`2N8"-:H0_M$`IJ@``I,#[^>SA3$8-IX1,%-,`"":`'L2`0"@D5*1&^ M:!B1A#&!CSPP9\1LH1%$DJQ=\G00&+,9H%5KNT@G6'%K^?K)(Q&(_#`-AB`! M+!!((Y`&I9`.)K$/[:`,G&`&1G$P10`$"0`@8\891D:+T1C,[M`0J*@2!=&2 M`^$/T^`+JV`)B+`';'`"!)!ZJ4<`"2`!&N`"8U`&:M`&)G=R*@<';]`&:V`& M9!`#*K`!'-`!#(``Q@/P@#I.@`5#@ M!4!@`RE@!CU;,29FB/)X.EGQD@1Q#LD@"YMP"'+@`@?P`3CUTB61$;TJ'6KX M0F,6MRL;VF1T#M&P"ZIP"8G0!VN@!!2@ J\!$O`!,_)`3S^,6<[ISQ8K<-) M@#=@$`11$`55\#*C-G@P,`:7W1"47(M-A1PP60[3,`RU@`J;\`B#H`=O4`:S M!-P(P`#(MP(CN)DP!5-L/)]33(2!(C]8@`4YP`(*3@+Z'`$<0`9O\`>.X`FP M4`SCH#^3@=YJR*'A-QJ7T8Y6X7FS8 ] FG`*I#`*IN`)E&`( M;V`!#\`A3D!M-\$"_Y$>\.+D8)AH@\'1>PT+HL`**\(0@AJ-.OY1(04H8)`" M:J`=^\40G#,.F7`"*P"B-1$Q!:`(33%/'Z&&OV)E_-`,=H``VLHN:=`+S-'( M3T[LW54\;,`W]S@;;/18B4`!- `G6GUC:[=Q.M#1XA]F%A"O,-(8TPSP`SZ0HU+@%_GG[OS7 M&4OO;CQF-8BB&[9V/^^4&5/G&7U3$=LF.Q)]CU_!#\4@"!_@`!;`![<@QB>* MKQ31&+TACU!!N=:HZ9PQ,&!A0WWCR3U)&$`35Y7^?61YWL?ILA$/D+.!#7"P M`CD;!G$)`GU@(62QD/Z0#<;0"[K0"P>=23/TD,U,>[MXANGQS+;`"\]P#L:) M9/\Z<]/P"[=`^P96$EJQY!RJ0X[A#]V`#,&@"[OP"V`.GV3^A`[64`RQL`F% MP`0`XW;N+D^RXP_CX`S#L`NG;PS3(.8GBN)_&KQ4]?1:AIQN@1V"JTPOC$;F M,`@2D+.Y6P-:4`$@1Q;8L`EQ$)T`,0*(CB OVEJ M"$B($*'"@$W\^!4KI*'!"!Y/2JB)-FX.@089)0RXY!%9(A4*.$S)$>*,,7Z; M"$3`F''`*'[Q_.FS%R\>OWVK]F!0T(&%%A@TGK!(`2%C@P8/$'18$8)(C2H* M5/'[I^_=1'^[&K&Y$*%#"QA/M.2`,8*KBCJ7D/&SYR]>TGCZ]L7"=(H3J73Z M/#[V..L"D2T_MH!)L:89OZ/Z#._^\WANTP<84,+0J.$#BH)0@/V)^D`BQY4G M36K,8%$"1I`@-6J`$1/BPRA_3.%YK`8G1)0K5ZI`D.0KS8,O.KP4B0+E`RU^ MVO*4N"(%3!$(D(2I6>`E"EDL,#2T\@CJP94B5\1<:6#*XSY]2\$=.F"V*W38 M(J<(&D"@`1;$6`\(+\2X;X4.&'A`!CZ,V<>=B6*AHP`63JO!B"N@F&$%$E(` MPHG[BDB"AA(.$.08?N!1BA]91AGED$Y8(0JRQR2CS+(J6F!#FW:2^8677%:Q M))`C&B`B##!JN.%!"-0`QJ-55&CA!QM\0&($)1Z)Q1AC>AFECPIF$\*&*#I( MXQ=^UN+^QYHX1ABBMQJ&P(*%*(B(P`,UV'@!)H^RL2,$)[;8PH@MJ'J4`4'; M6(*`28[BYY,(G!A"/"(J.(4?>>29Z)876/#AABN<"&&-5 %E&&F):2638YL3XX88H'I"#I\+^ M>8425"X919WC?.1GE@THVX%1,+ZPH`&Z =[O`HH0@(KTAB"Q9>$*4='_^)YSCYIA!Q/`[TZX^?8\S^F($&*<2@@8+6 M[+%G'WC6FJB8-%808XLPKI"@$X<>XJ<<0B"`<`@?7$YC%H_<><?^31D!]D MZFB`N2NV:((&!S#9QYYW(O(HGH7)+9<#(GY(MX@;FI""Y1NV(,()(N!-(00$ M3BA$EN*0;J<0!6AP`@L>6#!#1K21(@RI?1I1``P:PF.!"3DS%H'1(L#`H@)) M_-EGL+2N!M:[$GACU`D'&"F.QG_&' /!**H=XLH("`$G:L]6PH>=^#QY[A. M)@""P1_`N((#*#&C>.Q#'A'I&;G^9L$!*0#.?308`R0J00D*5J(2G3`%+9"A MCL=`I'CRD5=S:("`UO`-,L8@@Q:V8)\K/.`0C;%3"`#XM@[P@1R`25KMSI>[ M/(2@"N'90@GF,`X<\FZUT'/3*03$4B1O<"0@PO` MQVQR-&'?_I8N,(A@#<](&K!\]1"(D,H>$#E*-O2P'!T``0Q2B((*,K"!#&C` MDY[ /,I$2*:TP!Q'DB40@P^"((8A=.!Z=H.'.DUHKBE4QGTL M6`,S'$(C^LUH7'3D1R_(T((A;`$(#N7!#[;Y!"!``0I2P&A&I4`$(E2!"!VC MP09
:%*4JA>-!/?(/E^HNIHT2HDV! MQ5F/P$.G#^"I3P'%,[,5AA_`B`,+&*6%)PQ!:%C0@A2&H,;PC&`"D3@'/]SA MCJ6\0@6)"P*C 2"QZ@F(HD$$`&L40`##-;0D'^<;:Z2B9=E5!G0 MN<[,,<4X`PL&6TX9B&TBBBPO4VSI2HU9-J4KU2Q.E^)9F8;VIJ05YE*(F5K$ M58`4HGK'/]A!B0FLH`J%R\L#%-``!B```0>8P`?2,`A38`,MZ^#>/T!3##,( M%@Q#^&@$4%&4?]P.,O(HC-[V40[^0'3`"5I`C12N*+_NEA=(=B620./[&,^< M8Q`-8*)S6OB(N@'2,3Y"FF,\@S;.8B,.(K`O9ED*&<[N%Z;]K>E_ GEW8!8M3DM[6@(300)/I`@=1B#H'%1@I-M* MBQR?3,`"(M$SW5U*,]9`@AO %)U1@$!Y&ROT@$I&EO*-XOUR* MG;!\TOMFMM8OO35HPSS:,2NQU[^.S!-VD[D'!,+#FU:U!]UQ0)^I`9XZ"$,8 MGA`".BAC?IXQ(-+\80D*W,`']\&"$Q8P"''8PQU(?/>EXWT936\:@?GC!RP^ MP`(=L`\)22A"!,P0"5I(XQRTV\ /',< M $(9=A;'+`:1`1A`B`;\GH$%>D2[>`#^V$>L!@TM1""$ MW]B+!6UX!F<,6-[[$5=I#;/$!4)P!1H,@4#TD4(*)K2`!D```B%@@11J,`4U M*$,?Q:F&QA17!2QT0`_@@+GS0",/5K\T!%+PZ!9$$&;^.`^M1^0'*"1``WFA ME`,K+LXI(C`#,,#N/E$;@N)89*R'$J$(2&`.)"B1!*`#[H"Q9`*'16BP*_`! M'Q@"(QB"K&``XRN!&7"H(O`:67(!3RB.PDB@0.J^6""`$!B!#B"!$G@`,]@, M5]LTSI*'A9F(8$B$)2B`%9B!M\$"",&H+;BV(F"!"$B`$V`$ "``#9HI;6@D8D8!D P@-V[`D=1)3/@B7?(QN<[*'0@!E;PA$DH M1T>H!%'^D`5H&)GN&KA\VK3]8*>D*!FE4(I?`991@2\0-)MVH$AT0(=T2`=V MH$BSB2]U.J"T@*1`3`JD0#41(SCNZ0\1`XQXT#,Y2HI1B:ZRDJ.T(`R&V89! M0(`<>`(?&`$U.!C`0*NY4H4,(`*"N((H2(!*P"%OZP]#`T;0>;*"S#-58[6' ME"^@Y!M6DR-FC$C.``=ET(55V`1'*(0^>`,F.`$,J(`$((`!<,L!,(`"D$L+ MLS`&L$N[]`H$,``$4(`(N``-<`$E,`,XZ(-`.`1(P(12<`5=((9H^`9U$$7( M@+E],!M@C*[!<`S*[`P7'#ARZ3%>>($1D`)ZB0"K8
#'LIP#-2`# M%9B`!"@^"$B!&0@:(FB!$2@!"."*"SB!(U@#/2#'2R`%6/B%E+`S'T&*8=1* M.>J^#N(' @5W*1,5H,(5V-(S-2GK&R':AB&6O@6 M1PB$.3@#%["`!X"`$F`!S>&H*)C^`AA@@1#PB@:@`!4X`SP8A$?8A%2H!6*H MAG*841]9BF,@@Q2(@B@0`PA0A.+X4!\YJ*;DAW0P*J)IS09PA.@ZBJX$48\( MTEO(!$(@ACF9,G)!/7@8AF((KC]UU$=%*[."C';8AF2XA5.HA$/0@S/0``N# M`!*`@1O$`B_``@`J`AK`B@EI``[P@"5H`ST(!$:PA%%PA5\PAC_H@*9[@BU( M`31(!?GQE2@;'LC@A4&8`"*X`B]``AJ8@$Y(IX$"EE=;-A_Q!VXP!E@(A4?X M`S90@0B`SQF``3(0!L#H+C^5+Z6A$:4P#$AE5T?E/EOZHVF-E6P@!E?H!&U] M@R7`@`C^0`#D@P&>>H)=Y0&IN8_F\$&">`) P+LA$((A&`(@^`$"J;_F>"@PJ((UPL-I88$. M,(`7"`;`N!MY1=3(/-K+W334T]S'6#56:S&/&!51@[O5>SD4+I &XBB6XBFFXBJVXBO&XBS6XBWFXB[V &XKD*"``[ ` end
"``L!`!PTW0C*(I@!:1ML8K9/_`<'"\C/_`Z+4*8&&.=--`'@T3`0:,$6D!
MP,(AO3;%0",D6]P=@-0ES+%\(S5^-SB-A>2GTV@_X-L+-VI^*QN[>"=0N
M6B>!OW/#=W_8IL<>_*9\Q;=^'F.`=N($GX`_*$<$?8-R)/=SK`!Q_YWG!/4$
M:F;P?4V@@008@/:Q<7]0$.<'`NFG60@X*$U`>141"G^R7=/W#)QW?TV`-`K%
M?X"0=OWV?Z7'<4)@9O`'?@4(<`'Q?';7!'+G89+P@M0W"0O'";KG`2Z'4&1F
M@W^`@T?`@2``>3DV&2-8@K-`A)-05T>8!"07?T=P,PTH#-=7=DTP;T4#>F&`
MA<6F@T#H@3W87SL("'/G=476A[,B)]`W7B,H!%TU"'YX,XM6#)SF`2&U!("T
M?QE(AQLHB1W(@T,`/#K6A90X!8&H!&-X!)0G+=Z0?XC4!`%TF!G*8!%BX
M>H8B"4&BB<%W!9VXAT%H>Q?!=ZA`=E\#B?]'@'10&`>KB`1K!X"6:%QNX`9R
M(HO]=W5A:(2#N%[`T0W`6(I+0$-W(P=$HFE04(QY^`=8P(PW6'=4!HVW^(WW
M@'O/P&F^:`3#M'UP,'3_5F>20'/G*`7B6(7D6(_F:(=%L"_WP(W20(I&TXY%
M@$HU2!E%&%@^1WS^V'/WB'Z;.`7>:(L/.03OAP_T-U*8P0>9$2N6Y9
M<&Y/=7XBF89$0')*2`P4&$9*``$.(&%I@'/H-@24MY2#Z`0J&6#*%@I?=X)]
M@`3Z935CV0V\>#3_-4D$%;!K